NCIC CTG, IND-205: A phase II study of PX-866 in patients with recurrent or metastatic castration-resistant prostate cancer (CRPC).
Sebastien J. Hotte
No relevant relationships to disclose
Elizabeth A. Eisenhauer
Research Funding - Oncothyreon
Anthony Michael Joshua
No relevant relationships to disclose
Vikaash Kumar
No relevant relationships to disclose
Susan Ellard
No relevant relationships to disclose
Richard William Gregg
No relevant relationships to disclose
Robyn Jane Macfarlane
No relevant relationships to disclose
Eric Winquist
No relevant relationships to disclose
Vamsee Torri
No relevant relationships to disclose
Joseph D. Ruether
No relevant relationships to disclose
Naveen S. Basappa
No relevant relationships to disclose
Ankineedu Saranya Kakumanu
No relevant relationships to disclose
Scott A. North
No relevant relationships to disclose
Christian K. Kollmannsberger
No relevant relationships to disclose
Anna Tinker
No relevant relationships to disclose
Deepu Mirchandani
Employment or Leadership Position - BC Cancer Agency
Aurelie Tassignon
No relevant relationships to disclose
Diana Felice Hausman
Employment or Leadership Position - Oncothyreon
Stock Ownership - Oncothyreon
Alison L Allan
Research Funding - Ontario Institute for Cancer Research
Kim N. Chi
No relevant relationships to disclose